Articles citing this paper
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)
Jeff Harrison, Paul Drury, C Raina Elley, Fionna Bell and Rod Jackson Suneela Mehta, Sue Wells, Tania Riddell, Andrew Kerr, Romana Pylypchuk, Roger Marshall, Shanthi Ameratunga, Wing Cheuk Chan, Simon Thornley, Sue Crengle,
3(2) pp.93 - 101
13 articles found in Crossref database.
“Whose data is it anyway?” The implications of putting small area-level health and social data online
Exeter Daniel John,
Rodgers Sarah, Sabel Clive Eric
Health Policy. 2014 114(1). p.88
Sex disparities in the management of coronary heart disease in general practices in Australia
Lee Crystal Man Ying,
Mnatzaganian George,
Woodward Mark,
Chow Clara K,
Sitas Freddy,
Robinson Suzanne, Huxley Rachel R
Heart. 2019 105(24). p.1898
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)
Wells Sue,
Riddell Tania,
Kerr Andrew,
Pylypchuk Romana,
Chelimo Carol,
Marshall Roger,
Exeter Daniel J.,
Mehta Suneela,
Harrison Jeff,
Kyle Cam,
Grey Corina,
Metcalf Patricia,
Warren Jim,
Kenealy Tim,
Drury Paul L.,
Harwood Matire,
Bramley Dale,
Gala Geeta, Jackson Rod
International Journal of Epidemiology. 2015 p.dyv312
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16
Mehta Suneela,
Wells Sue,
Grey Corina,
Riddell Tania,
Kerr Andrew,
Marshall Roger,
Ameratunga Shanthi,
Harrison Jeff,
Kenealy Tim,
Bramley Dale,
Chan Wing Cheuk,
Thornley Simon,
Sundborn Gerhard, Jackson Rod
European Journal of Preventive Cardiology. 2014 21(2). p.192
Stroke Prevention in New Zealand: Can We Do Better?
Feigin Valery L.,
Krishnamurthi Rita,
Barber P. Alan, Arroll Bruce
International Journal of Stroke. 2014 9(1). p.61
Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk
Nghiem Nhung,
Knight Josh,
Mizdrak Anja,
Blakely Tony, Wilson Nick
Scientific Reports. 2019 9(1).
Factors influencing adherence in long‐term use of statins
Warren James R.,
Falster Michael O.,
Fox Danushka, Jorm Louisa
Pharmacoepidemiology and Drug Safety. 2013 22(12). p.1298
Prevention of stroke: a strategic global imperative
Feigin Valery L.,
Norrving Bo,
George Mary G.,
Foltz Jennifer L.,
Roth Gregory A., Mensah George A.
Nature Reviews Neurology. 2016 12(9). p.501
The cultural safety of research reports on primary healthcare use by Indigenous Peoples: a systematic review
Hiyare-Hewage Amandi,
Sinka Victoria,
Grande Eleonora Dal,
Kerr Marianne,
Kim Siah,
Mallitt Kylie-Ann,
Dickson Michelle,
Jaure Allison,
Wilson Rhonda,
Craig Jonathan C., Stephens Jacqueline H.
BMC Health Services Research. 2024 24(1).
A New Paradigm for Primary Prevention Strategy in People with Elevated Risk of Stroke
Feigin Valery L., Norrving Bo
International Journal of Stroke. 2014 9(5). p.624
To move or not to move? Exploring the relationship between residential mobility, risk of cardiovascular disease and ethnicity in New Zealand
Darlington-Pollock Frances,
Norman Paul,
Lee Arier C.,
Grey Corina,
Mehta Suneela, Exeter Daniel J.
Social Science & Medicine. 2016 165 p.128
Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?
Bartlett Louise E.,
Pratt Nicole, Roughead Elizabeth E.
Current Medical Research and Opinion. 2018 34(2). p.305
Improving adherence using combination therapy (IMPACT): Design and protocol of a randomised controlled trial in primary care
Selak Vanessa,
Elley C. Raina,
Crengle Sue,
Harwood Matire,
Doughty Rob,
Arroll Bruce,
Bryant Linda,
Rafter Natasha,
Hoorn Stephen Vander,
Wadham Angela,
Wells Sue,
Milne Richard,
Jackson Rod,
Bramley Dale, Rodgers Anthony
Contemporary Clinical Trials. 2011 32(6). p.909
